MyFinsight
Home
Blog
About
Back
Cash Flow
GT Biopharma, Inc. (GTBP)
GT Biopharma, Inc. (GTBP)
source: myfinsight.com
Proceeds from issuance of
series l convertible...
$297K
(-94.54%↓ Y/Y)
Net cash provided by
financing activities
$297K
(-95.43%↓ Y/Y)
Net increase
(decrease) in cash and cash...
-$3,963K
(-410.34%↓ Y/Y)
Canceled cashflow
$297K
(increase) decrease in
prepaid expenses
-$409K
(-281.78%↓ Y/Y)
Fair value of vested
stock options
$92K
Net cash used in
operating activities
-$4,260K
(18.33%↑ Y/Y)
Canceled cashflow
$501K
Net loss
-$4,518K
(-104.53%↓ Y/Y)
Increase (decrease) in
accounts payable and...
-$197K
(87.86%↑ Y/Y)
Back